Subscribe to Search results

In his written statement to the Inquiry, Dr Lloyd commented that the RIBA II assay "appeared to substantially remove the issue of lack of specificity. Once the RIBA II test was available, the lack of specificity with the first-generation test would have been much more manageable".

Published on:

Dr Gunson noted that Chiron had announced that it was working on a recombinant immunoblot assay confirmatory test, but that it was not yet available.

Published on:

Dr Barbara's written evidence to this Inquiry was that the second-round comparative evaluation of test kits needed to be completed and to gain more experience in confirmatory assays before reliable and more accurate and specific testing could begin with workable methods for determining the infection status of the donor.

Published on:

The Chief Medical Officer endorsed the recommendation that routine screening should be introduced as a public health measure.

Published on:

A draft circular on changes to blood handling charges circulated to recipients in the Department of Health stated: "Ministers have agreed that screening for HCV should be introduced as a public health measure. A starting date of 1 July has been set".

Published on:

Dr Harrison was supportive of the coordinated national start date.

Published on:

Dr Gunson wrote to Graham Hart, then director of operations of the NHS Management Board in the Department of Health, outlining the development of the Chiron/Ortho test.

Published on:

Following a meeting of ACVSB, Dr Metters wrote to Dr Rejman, outlining that it would be far more difficult to demonstrate the practical benefits from the introduction of the Chiron test.

Published on:

Dr Metters wrote to Mike Malone-Lee outlining prior warning of the likely cost if the ACVSB were to recommend introducing Hepatitis C screening for all blood donations.

Published on:

According to John Canavan, the suggestion that assessment of the relative merits of the two tests could have been undertaken concurrently with the implementation of the screening would have raised significant operational considerations for the RTCs in terms of staffing, equipment and donor counselling arrangements.

Published on:

The Glasgow RTC, the largest in Scotland, was evaluating the Abbott test.

Published on:

Dr Gunson estimated that the annual costs of routine anti-HCV tests on blood donations in England and Wales would amount to (at least) £5,620,000.

Published on:

Dr Gunson followed up on the £25,000 grant of funding by writing to Dr Kennedy at the NHS Procurement Directorate submitting a draft protocol for a pilot study in Birmingham, Sheffield and Brentwood.

Published on:

Dr Metters wrote a briefing for the Chief Medical Officer, Sir Donald Acheson, informing him of the ACVSB's recommendations and the funding (an estimated £150,000) that would be required for the pilot study.

Published on:

John Canavan wrote a memo to Miss Wheeler regarding the funding of anti-HCV tests. Ortho would not provide free tests for these free trials and as such they would need to be purchased at a total cost of 25,000 oounds . John Canavan was to seek confirmation where these funds would come from.

Published on:

A submission estimated the cost of introducing screening for HCV antibodies at £5.73 million in the first year, with lessening costs subsequently and that it "would add nearly £6 million to the RTCs['] revenue operating costs of approximately £70m pa."

Published on:

The second payment to the Macfarlane Trust proposed in late 1989 was made at a time when "public pressure for some further action" was "intense".

Published on:

Professor Bloom wrote a letter referring to "inaccurate statements in the press" and asserted that "we are unaware of any proven case in our own haemophiliac population" which was a disingenuous half-truth, given his own knowledge of a probable case amongst patients of the Cardiff Centre.

Published on:

Professor Bloom's letter was published by the Haemophilia Society with the comment that "In view of the unduly alarmist reports on AIDS which appeared in the press over the weekend, we are writing to reassure members of the Society about the true position."

Published on:

The first payment made to the Macfarlane Trust was a response to the "considerable parliamentary and public pressure...to do something"

Published on: